Folgen
Jan ter Meulen
Jan ter Meulen
Chief Scientific Officer at Obsidian Therapeutics
Bestätigte E-Mail-Adresse bei mailer.uni-marburg.de
Titel
Zitiert von
Zitiert von
Jahr
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
M Throsby, E van den Brink, M Jongeneelen, LLM Poon, P Alard, ...
PloS one 3 (12), e3942, 2008
8782008
Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants
J Ter Meulen, EN Van Den Brink, LLM Poon, WE Marissen, CSW Leung, ...
PLoS medicine 3 (7), e237, 2006
6852006
The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P
O Lenz, J ter Meulen, HD Klenk, NG Seidah, W Garten
Proceedings of the National Academy of Sciences 98 (22), 12701-12705, 2001
4352001
Hantavirus in African wood mouse, Guinea
B Klempa, E Fichet-Calvet, E Lecompte, B Auste, V Aniskin, H Meisel, ...
Emerging infectious diseases 12 (5), 838, 2006
4012006
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups
CK Ong, SY Chan, MS Campo, K Fujinaga, P Mavromara-Nazos, ...
Journal of virology 67 (11), 6424-6431, 1993
3181993
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
J Ter Meulen, ABH Bakker, EN Van Den Brink, GJ Weverling, ...
The Lancet 363 (9427), 2139-2141, 2004
3122004
Lassa virus Z protein is a matrix protein sufficient for the release of virus-like particles
T Strecker, R Eichler, J Meulen, W Weissenhorn, H Dieter Klenk, ...
Journal of virology 77 (19), 10700-10705, 2003
2862003
Mastomys natalensis and lassa fever, West Africa
E Lecompte, E Fichet-Calvet, S Daffis, K Koulémou, O Sylla, F Kourouma, ...
Emerging infectious diseases 12 (12), 1971, 2006
2642006
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
G Bommakanti, MP Citron, RW Hepler, C Callahan, GJ Heidecker, ...
Proceedings of the National Academy of Sciences 107 (31), 13701-13706, 2010
2622010
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind
SY Chan, L Ho, CK Ong, V Chow, B Drescher, M Dürst, J Ter Meulen, ...
Journal of virology 66 (4), 2057-2066, 1992
2471992
Imported lassa fever in Germany: molecular characterization of a new lassa virus strain.
S Günther, P Emmerich, T Laue, O Kühle, M Asper, A Jung, T Grewing, ...
Emerging infectious diseases 6 (5), 466, 2000
2422000
Isolation and characterization of human monoclonal antibodies from individuals infected with West Nile Virus
M Throsby, C Geuijen, J Goudsmit, AQ Bakker, J Korimbocus, RA Kramer, ...
Journal of virology 80 (14), 6982-6992, 2006
2272006
Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea
J Ter Meulen, I Lukashevich, K Sidibe, A Inapogui, M Marx, A Dorlemann, ...
American Journal of Tropical Medicine and Hygiene 55, 661-666, 1996
2261996
Novel hantavirus sequences in shrew, Guinea
B Klempa, E Fichet-Calvet, E Lecompte, B Auste, V Aniskin, H Meisel, ...
Emerging Infectious Diseases 13 (3), 520, 2007
2072007
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany
S Günther, H Feldmann, TW Geisbert, LE Hensley, PE Rollin, ST Nichol, ...
The Journal of infectious diseases 204 (suppl_3), S785-S790, 2011
1882011
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus
EN van den Brink, J Ter Meulen, F Cox, MAC Jongeneelen, A Thijsse, ...
Journal of virology 79 (3), 1635-1644, 2005
1852005
The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease
BAG Coller, DE Clements, AJ Bett, SL Sagar, JH Ter Meulen
Vaccine 29 (42), 7267-7275, 2011
1802011
Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection
R Sommerstein, L Flatz, MM Remy, P Malinge, G Magistrelli, N Fischer, ...
PLoS pathogens 11 (11), e1005276, 2015
1732015
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene
S Vieth, C Drosten, O Lenz, M Vincent, S Omilabu, M Hass, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 101 (12 …, 2007
1522007
Fluctuation of Abundance and Lassa Virus Prevalence in Mastomys natalensis in Guinea, West Africa
E Fichet-Calvet, E Lecompte, L Koivogui, B Soropogui, A Doré, ...
Vector-Borne and Zoonotic Diseases 7 (2), 119-128, 2007
1472007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20